These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Abboud RT; Vimalanathan S Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259 [TBL] [Abstract][Full Text] [Related]
3. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management? Stockley RA; Edgar RG; Pillai A; Turner AM Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086 [TBL] [Abstract][Full Text] [Related]
4. Impact of inflammation, emphysema, and smoking cessation on V/Q in mouse models of lung obstruction. Jobse BN; McCurry CA; Morissette MC; Rhem RG; Stämpfli MR; Labiris NR Respir Res; 2014 Apr; 15(1):42. PubMed ID: 24730756 [TBL] [Abstract][Full Text] [Related]
6. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Silverman EK; Chapman HA; Drazen JM; Weiss ST; Rosner B; Campbell EJ; O'DONNELL WJ; Reilly JJ; Ginns L; Mentzer S; Wain J; Speizer FE Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1770-8. PubMed ID: 9620904 [TBL] [Abstract][Full Text] [Related]
7. A quantitative study of the relationship between chronic bronchitis, emphysema and smoking. Dunnill MS; Ryder R Chest; 1971 May; 59():Suppl:35S+. PubMed ID: 5575683 [No Abstract] [Full Text] [Related]
8. [Mechanisms of bronchial obstruction in COPD and emphysema: from anatomopathology to respiratory function]. Saetta M Rev Mal Respir; 1998 Sep; 15 Suppl 2():S17-9. PubMed ID: 9809337 [No Abstract] [Full Text] [Related]
10. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Maestrelli P; Saetta M; Mapp CE; Fabbri LM Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S76-80. PubMed ID: 11734472 [TBL] [Abstract][Full Text] [Related]
11. COPD: obstructed lungs. Casey G Nurs N Z; 2016 Jun; 22(5):20-4. PubMed ID: 27514228 [TBL] [Abstract][Full Text] [Related]
12. [Smokers with chronic bronchitis and emphysema. Utilize the entire therapy spectrum!]. Jany B MMW Fortschr Med; 2000 Feb; 142(6):30-3. PubMed ID: 10832348 [TBL] [Abstract][Full Text] [Related]
16. Alpha-1-antitrypsin and other proteinase inhibitors. Miravitlles M Curr Opin Pharmacol; 2012 Jun; 12(3):309-14. PubMed ID: 22365503 [TBL] [Abstract][Full Text] [Related]
17. Morphological and cellular basis for airflow limitation in smokers. Saetta M; Finkelstein R; Cosio MG Eur Respir J; 1994 Aug; 7(8):1505-15. PubMed ID: 7957838 [TBL] [Abstract][Full Text] [Related]
18. [Current views on the pathogenesis and treatment of pulmonary emphysema and chronic bronchitis]. Fal A Wiad Lek; 1992 Mar; 45(5-6):233-9. PubMed ID: 1455869 [TBL] [Abstract][Full Text] [Related]
19. The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease. O'Brien ME; Pennycooke K; Carroll TP; Shum J; Fee LT; O'Connor C; Logan PM; Reeves EP; McElvaney NG COPD; 2015 May; 12 Suppl 1():2-9. PubMed ID: 25938284 [TBL] [Abstract][Full Text] [Related]
20. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]